- Home
- BCML vs ANL Comparison
BCML vs ANL Comparison
Compare BCML & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | BCML | ANL |
|---|---|---|
| Founded | 2004 | 2004 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.2M | 293.4M |
| IPO Year | 2018 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BCML | ANL |
|---|---|---|
| Price | $28.98 | $6.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $34.00 | $16.00 |
| AVG Volume (30 Days) | 16.1K | ★ 181.7K |
| Earning Date | 04-16-2026 | 04-20-2026 |
| Dividend Yield | ★ 4.11% | N/A |
| EPS Growth | ★ 3.81 | N/A |
| EPS | ★ 2.18 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.71 | N/A |
| Revenue Next Year | $5.25 | N/A |
| P/E Ratio | $13.40 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.22 | $0.88 |
| 52 Week High | $33.15 | $12.09 |
Technical Indicators
Market Signals| Indicator | BCML | ANL |
|---|---|---|
| Relative Strength Index (RSI) | 44.15 | 36.85 |
| Support Level | $28.12 | $1.36 |
| Resistance Level | $30.66 | $9.98 |
| Average True Range (ATR) | 0.84 | 0.76 |
| MACD | 0.04 | -0.24 |
| Stochastic Oscillator | 31.28 | 5.56 |
Price Performance
Historical ComparisonAbout BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses, and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services. The Company operates as one reportable segment: banking operations.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.